
CVS Health Corporation CVS
$ 89.44
1.15%
CVS Health Corporation EV/EBITDA Ratio | CVS
Annual EV/EBITDA Ratio CVS Health Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.7 | 19 | 14.5 | 21.5 | 16.2 | 13.3 | 9.38 | 10.7 | 8.82 | 8.33 | 11.5 | 11.5 | 9.25 | 8.17 | 8.19 | 5.98 | 5.48 | 8.18 | 8.51 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 28.7 | 5.48 | 12 |
EV/EBITDA Ratio of other stocks in the Health care industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
UnitedHealth Group Inc.
UNH
|
19.3 | $ 402.88 | -0.55 % | $ 366 B | ||
|
Humana
HUM
|
14.7 | $ 447.96 | 2.28 % | $ 54 B | ||
|
Triple-S Management Corporation
GTS
|
79.5 | - | 0.28 % | $ 847 M | ||
|
NovoCure Limited
NVCR
|
-13.6 | $ 11.99 | 1.48 % | $ 1.34 B | ||
|
Molina Healthcare
MOH
|
14.3 | $ 208.96 | 1.29 % | $ 11 B | ||
|
Magellan Health, Inc.
MGLN
|
16.1 | - | -0.19 % | $ 2.49 B | ||
|
Anthem
ANTM
|
7.77 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
15.4 | $ 301.34 | -0.6 % | $ 79.4 B | ||
|
Centene Corporation
CNC
|
-9.32 | $ 70.57 | 0.52 % | $ 34.8 B |